Discover
CATX
Perspective Therapeutics, Inc.
2.98
1 x 2.64
1 x 3.26
bid
ask
+
0.06
2.05%
1 @ 04:00 PM
2.89 -0.09 (3.02%)
| Ytd | 8.36% | |
| 1y | -30.86% |
2.92
day range
3.02
1.96
52 week range
6.16
| Open | 2.95 | Prev Close | 2.92 | Low | 2.92 | High | 3.02 | Mkt Cap | 230.21M |
| Vol | 873.94K | Avg Vol | 1.84M | EPS | -1.41 | P/E | -2.11 | Forward P/E | -2.91 |
| Beta | 1.74 | Short Ratio | 4.69 | Inst. Own | 81.43% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-11 | 50-d Avg | 3.38 | 200-d Avg | 3.58 | 1yr Est | 16.15 |
| Income Statement | |||
| Total Revenue | 76.00K | ||
| Revenues (USD) | 76.00K | ||
| Gross Profit | 76.00K | ||
| Operating Expenses | 28.36M | ||
| Research and Development Expense | 21.37M | ||
| Selling, General and Administrative Expense | 6.99M | ||
| Operating Income | -28.28M | ||
| Interest Expense | 105.00K | ||
| Net Income | -26.19M | ||
| Net Income Common Stock | -26.19M | ||
| Net Income Common Stock (USD) | -26.19M | ||
| Consolidated Income | -26.19M | ||
| Earnings per Basic Share | -0.25 | ||
| Earnings per Basic Share (USD) | -0.25 | ||
| Earnings per Diluted Share | -0.25 | ||
| Earning Before Interest & Taxes (EBIT) | -26.08M | ||
| Earning Before Interest & Taxes (USD) | -26.08M | ||
| Weighted Average Shares | 103.60M | ||
| Weighted Average Shares Diluted | 103.60M | ||
| Balance Sheet | |||
| Cash and Equivalents | 53.97M | ||
| Cash and Equivalents (USD) | 53.97M | ||
| Investments | 216.96M | ||
| Investments Current | 216.96M | ||
| Trade and Non-Trade Receivables | 58.00K | ||
| Current Assets | 275.35M | ||
| Property, Plant & Equipment Net | 94.93M | ||
| Total Assets | 410.77M | ||
| Debt Current | 1.13M | ||
| Total Debt | 4.23M | ||
| Current Liabilities | 31.49M | ||
| Debt Non-Current | 3.11M | ||
| Total Liabilities | 63.33M | ||
| Accumulated Retained Earnings (Deficit) | -361.03M | ||
| Accumulated Other Comprehensive Income | -226.00K | ||
| Shareholders Equity | 347.44M | ||
| Shareholders Equity (USD) | 347.44M | ||
| Assets Non-Current | 135.42M | ||
| Total Debt (USD) | 4.23M | ||
| Deferred Revenue | 26.60M | ||
| Goodwill and Intangible Assets | 40.00M | ||
| Liabilities Non-Current | 31.85M | ||
| Trade and Non-Trade Payables | 26.49M | ||
| Tax Liabilities | 1.70M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.13M | ||
| Net Cash Flow from Financing | 164.36M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 23.34M | ||
| Capital Expenditure | -6.86M | ||
| Issuance (Purchase) of Equity Shares | 164.38M | ||
| Issuance (Repayment) of Debt Securities | -15.00K | ||
| Net Cash Flow from Investing | -109.55M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -102.69M | ||
| Net Cash Flow from Operations | -31.47M | ||
| Share Based Compensation | 2.55M | ||